Regulatory B Cell Markers

Click on one of the B cell subsets shown in the buttons below to see the human and mouse markers that are commonly used to identify each cell type.

Regulatory B Cell Markers
Human
Cell Surface Markers
CD1dhigh
ProductsClose
CD5+
ProductsClose
CD5
CD19+
ProductsClose
CD20/MS4A1-/low
ProductsClose
CD21high
ProductsClose
CD24high
ProductsClose
CD27+/-
ProductsClose
CD38high
ProductsClose
CD40+
ProductsClose
IgD+/-
IgMhigh
Mouse
Cell Surface Markers
B220/CD45R+
ProductsClose
CD1dhigh
ProductsClose
CD5+
ProductsClose
CD5
CD19+
ProductsClose
CD21high
ProductsClose
CD23/Fc epsilon RIIlow/+
CD24+
ProductsClose
CD40+
ProductsClose
CD93/C1q R1-/low
ProductsClose
IgD+
IgMhigh
L-Selectin/CD62L-
ProductsClose
TIM-1+
ProductsClose
Intracellular Markers
EBF-1+
ProductsClose
E2A+
ProductsClose
Oct2+
Pax5+
ProductsClose
Secreted Factors
IL-10
ProductsClose
IL-35
TGF-beta
Regulatory B Cell Markers

Overview

Regulatory B cells (Bregs) are a subset of IL-10-producing B cells involved in the maintenance of tolerance and the restoration of homeostasis following inflammation. Although multiple subsets of IL-10-producing B cells exist in mice, the most widely investigated Bregs are splenic B10 cells. Mouse B10 cells have been characterized as CD19+CD5+CD1d+ cells, but these surface markers typically overlap with those of other B cell subsets. As a result, B10 cells in mice are commonly identified by their functional ability to produce IL-10 following stimulation with lipopolysaccharide or CpG oligonucleotides, phorbol myristate acetate (PMA), and ionomycin. In addition to IL-10, secretion of TGF-β and IL-35 may also contribute to Breg-mediated immunosuppression. In humans, several IL-10-producing Breg subsets have been identified in the peripheral blood. The counterpart of mouse B10 cells are human CD19+CD24+CD27+IL-10+ B10 cells. Other human B cell subsets with suppressive effects include an immature B cell population that has been characterized as CD19+CD24highCD38highIL-10+ and a second plasmablast population that is CD19+CD24highCD27intCD44highSyndecan-1/CD138+IL-10+.